Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Uniphar Group PLC

Healthcare GB UPR

414.0GBX
8.00(1.97%)

Last update at 2026-06-05T14:32:00Z

Day Range

406.60420.00
LowHigh

52 Week Range

218.59368.00
LowHigh

Fundamentals

  • Previous Close 406.00
  • Market Cap906.31M
  • Volume15284
  • P/E Ratio20.00
  • Dividend Yield0.60%
  • EBITDA107.44M
  • Revenue TTM3074.70M
  • Revenue Per Share TTM11.74
  • Gross Profit TTM 457.69M
  • Diluted EPS TTM0.17

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 62.92M 75.59M 52.90M 54.68M 55.80M
Minority interest -0.03900M -0.03300M -0.33300M -0.11900M -0.04500M
Net income 51.07M 64.20M 44.81M 45.59M 48.08M
Selling general administrative 381.11M 260.94M 235.65M 183.69M 154.47M
Selling and marketing expenses - 82.02M 76.98M 70.06M 60.71M
Gross profit 457.54M 427.60M 389.98M 306.74M 274.50M
Reconciled depreciation 35.71M 35.36M 35.41M 28.47M 26.93M
Ebit 91.11M 101.08M 77.49M 53.16M 45.15M
Ebitda 126.81M 136.44M 112.90M 81.38M 86.22M
Depreciation and amortization 35.70M 35.36M 35.41M 28.23M 41.07M
Non operating income net other - - - - -
Operating income 91.11M 81.99M 67.71M 53.16M 45.15M
Other operating expenses 2982.60M 2688.44M 2485.35M 2017.51M 1883.60M
Interest expense 20.37M 25.49M 24.59M 9.29M 6.93M
Tax provision 11.81M 11.36M 7.75M 8.97M 7.68M
Interest income 1.55M 1.90M 0.59M 0.10M 0.04M
Net interest income -19.63700M -24.02000M -21.92400M -9.53300M -7.19200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 11.81M 11.36M 7.75M 8.97M 7.68M
Total revenue 3073.71M 2770.43M 2553.06M 2070.67M 1943.15M
Total operating expenses 366.44M 345.62M 322.28M 253.59M 214.95M
Cost of revenue 2616.16M 2342.82M 2163.08M 1763.92M 1668.65M
Total other income expense net -28.18587M -6.39500M -14.81000M 1.52M 10.65M
Discontinued operations - - - - -
Net income from continuing ops 51.13M 64.24M 45.15M 45.71M 48.12M
Net income applicable to common shares - - - 45.59M 48.08M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1731.70M 1415.84M 1289.56M 1110.79M 944.99M
Intangible assets 93.54M 59.70M 44.56M 24.46M 20.78M
Earning assets - - - - -
Other current assets - 11.87M 34.88M 165.81M -129340.34300M
Total liab 1326.66M 1013.96M 955.94M 821.01M 693.43M
Total stockholder equity 404.87M 401.75M 332.80M 289.54M 251.44M
Deferred long term liab - - - - -
Other current liab 9.28M 212.70M 217.56M 4.59M 4.29M
Common stock 20.76M 21.84M 21.84M 21.84M 21.84M
Capital stock 20.77M 21.84M 21.84M 21.84M 21.84M
Retained earnings 199.82M 188.62M 128.21M 88.48M 47.55M
Other liab - - - 94.06M 90.40M
Good will 499.41M 507.61M 517.09M 482.98M 425.16M
Other assets - - - 9.53M 2.55M
Cash 183.87M 102.99M 85.65M 103.70M 78.03M
Cash and equivalents - - - - -
Total current liabilities 834.58M 630.71M 573.96M 433.60M 373.71M
Current deferred revenue - - 197.85M - -4.29500M
Net debt 463.89M 303.16M 296.34M 211.45M 167.38M
Short term debt 22.33M 31.90M 33.30M 21.80M 16.08M
Short long term debt 0.00000M 9.32M 13.17M 7.49M 1.72M
Short long term debt total 647.77M 406.15M 381.99M 315.15M 245.40M
Other stockholder equity 177.14M 176.50M 176.50M 179.23M 182.05M
Property plant equipment - - - 166.63M 152.48M
Total current assets 828.65M 553.75M 507.93M 427.17M 343.99M
Long term investments - - - - -
Net tangible assets - - - -217.89600M -194.49300M
Short term investments - - - - -
Net receivables 349.60M 237.31M 202.85M 164.21M 129494.00M
Long term debt 355.07M 241.65M 222.60M 187.43M 124.60M
Inventory 295.18M 201.58M 184.55M 157.66M 112.31M
Accounts payable 802.97M 375.21M 299.18M 407.21M 357.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.14M 14.80M 6.25M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 1.24M 13.25M 0.53M 0.41M
Deferred long term asset charges - - - - -
Non current assets total 903.05M 862.09M 781.63M 683.62M 601.00M
Capital lease obligations 157.62M 155.19M 146.22M 120.23M 119.08M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -96.47900M -90.42800M -106.33200M -49.65800M
Change to liabilities - - - 2.70M 13.39M
Total cashflows from investing activities -77.10402M -96.47900M -90.42800M -106.33200M -49.65800M
Net borrowings 106.43M 12.53M 41.43M 55.41M 15.89M
Total cash from financing activities 50.09M -11.48800M 19.63M 50.41M 13.26M
Change to operating activities - - - - -
Net income 51.07M 85.15M 77.75M 69.57M 59.55M
Change in cash 85.87M 17.34M -18.05200M 25.68M 17.61M
Begin period cash flow 98.00M 85.65M 103.70M 78.03M 60.41M
End period cash flow 183.87M 102.99M 85.65M 103.70M 78.03M
Total cash from operating activities 108.40M 124.27M 52.51M 82.83M 52.18M
Issuance of capital stock - - - - -
Depreciation 35.70M 35.36M 35.41M 28.47M 26.93M
Other cashflows from investing activities - -22.35400M -8.10500M - -
Dividends paid 5.08M 5.08M 4.83M 4.67M 5.73M
Change to inventory -93.52869M -17.15900M -16.86800M -15.13000M 3.73M
Change to account receivables -98.34913M -18.37800M -67.07300M 2.93M -26.16900M
Sale purchase of stock -35.08863M 0.00000M - - -
Other cashflows from financing activities -25.44975M -18.93900M -16.96600M 84.65M 32.94M
Change to netincome - - - 18.27M -13.77500M
Capital expenditures 23.53M 102.09M 31.95M 19.92M 14.43M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 45.13M 48.89M -16.22400M -9.49600M -9.05500M
Stock based compensation 3.77M 2.94M 2.83M 0.54M -
Other non cash items -23.50238M -48.07600M -47.25100M -6.24800M -25.24900M
Free cash flow 84.86M 22.18M 20.56M 62.91M 37.75M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
UPR
Uniphar Group PLC		 8.00 1.97% 414.00 20.00 15.53 0.29 2.44 0.44 11.21

Reports Covered

Stock Research & News

View All

Profile

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

Uniphar Group PLC

4045 Kingswood Road, Dublin, Ireland, D24 V06K

Key Executives

Name Title Year Born
Mr. Gerard Rabbette B.Comm FCA CEO & Exec. Director NA
Mr. Timothy Dolphin B.Comm FCA CFO & Exec. Director NA
Mr. Padraic Dempsey Chief Commercial Officer NA
Mr. Seamus Egan Head of Corp. Devel. & Investor Relations NA
Ms. Aisling McCarthy Gen. Counsel & Company Sec. NA
Mr. Dermot Ryan Managing Director NA
Mr. Gerard Rabbette B.Comm FCA CEO & Executive Director NA
Mr. Timothy Dolphin B.Comm FCA CFO & Executive Director NA
Mr. Allan Smylie C.F.A. Head of Strategy and Investor Relations NA
Ms. Aisling McCarthy General Counsel & Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions